Akoya Biosciences, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
AKYA on Nasdaq
Location
100 Campus Drive, 6 Th Floor, Marlborough, Massachusetts

Insiders trading volume in the past year

Akoya Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas A. Raffin Director $72.4M Jun 4, 2024
Matthew Winkler Director $4.41M Jun 4, 2024
Robert Shepler Director $2.23M Jun 4, 2024
Joseph Driscoll Chief Financial Officer $1.17M Dec 22, 2022
Niro Ramachandran Chief Business Officer $996K Mar 23, 2024
John Frederick Ek Cfo $915K Apr 1, 2024
Jennifer Kamocsay General Counsel $598K Feb 22, 2024
Frederic Pla Chief Operating Officer $582K +$92K +18.8% Mar 23, 2024
Brian McKelligon President and CEO, Director $468K -$240K -33.9% Jun 11, 2024
Scott Mendel Director $128K Jun 4, 2024
Myla Lai Director $89.5K Jun 4, 2024
Marilee Moy Chief People Officer $89.5K Feb 23, 2023
Ehab El-Gabry Chief Medical Officer $72.7K Feb 23, 2023
Garry Nolan Director Jun 1, 2023
Thomas P. Schnettler Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Akoya Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.